nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.113	0.185	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.113	0.185	CbGbCtD
Lercanidipine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0849	0.139	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.052	0.0849	CbGbCtD
Lercanidipine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.052	0.0849	CbGbCtD
Lercanidipine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.039	0.0637	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0357	0.0583	CbGbCtD
Lercanidipine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0356	0.0582	CbGbCtD
Lercanidipine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0331	0.0541	CbGbCtD
Lercanidipine—CACNA1D—cochlear duct of membranous labyrinth—peripheral nervous system neoplasm	0.0164	0.473	CbGeAlD
Lercanidipine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0152	0.0248	CbGbCtD
Lercanidipine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0149	0.0244	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0139	0.0228	CbGbCtD
Lercanidipine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0095	0.0155	CbGbCtD
Lercanidipine—CACNA1D—cochlea—peripheral nervous system neoplasm	0.00833	0.24	CbGeAlD
Lercanidipine—CACNA1D—internal ear—peripheral nervous system neoplasm	0.00789	0.227	CbGeAlD
Lercanidipine—CACNA1D—cerebellum—peripheral nervous system neoplasm	0.000709	0.0204	CbGeAlD
Lercanidipine—CACNA1C—cerebellum—peripheral nervous system neoplasm	0.000654	0.0188	CbGeAlD
Lercanidipine—Nisoldipine—ABCB1—peripheral nervous system neoplasm	0.000616	0.243	CrCbGaD
Lercanidipine—Nitrendipine—ABCB1—peripheral nervous system neoplasm	0.000576	0.228	CrCbGaD
Lercanidipine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000482	0.0139	CbGeAlD
Lercanidipine—Felodipine—ABCB1—peripheral nervous system neoplasm	0.000458	0.181	CrCbGaD
Lercanidipine—Nifedipine—ABCB1—peripheral nervous system neoplasm	0.000443	0.175	CrCbGaD
Lercanidipine—Nicardipine—ABCB1—peripheral nervous system neoplasm	0.000436	0.172	CrCbGaD
Lercanidipine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000238	0.00684	CbGeAlD
Lercanidipine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00021	0.0006	CcSEcCtD
Lercanidipine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00021	0.000598	CcSEcCtD
Lercanidipine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00021	0.000598	CcSEcCtD
Lercanidipine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000597	CcSEcCtD
Lercanidipine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000595	CcSEcCtD
Lercanidipine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000207	0.000591	CcSEcCtD
Lercanidipine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000207	0.000591	CcSEcCtD
Lercanidipine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000207	0.000589	CcSEcCtD
Lercanidipine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000207	0.000589	CcSEcCtD
Lercanidipine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000207	0.000589	CcSEcCtD
Lercanidipine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000206	0.000587	CcSEcCtD
Lercanidipine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000206	0.000586	CcSEcCtD
Lercanidipine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000205	0.000583	CcSEcCtD
Lercanidipine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000583	CcSEcCtD
Lercanidipine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000582	CcSEcCtD
Lercanidipine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000582	CcSEcCtD
Lercanidipine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000579	CcSEcCtD
Lercanidipine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000575	CcSEcCtD
Lercanidipine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000202	0.000575	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000573	CcSEcCtD
Lercanidipine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000573	CcSEcCtD
Lercanidipine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000201	0.000573	CcSEcCtD
Lercanidipine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.00057	CcSEcCtD
Lercanidipine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.00057	CcSEcCtD
Lercanidipine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000569	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000199	0.000569	CcSEcCtD
Lercanidipine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000565	CcSEcCtD
Lercanidipine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000198	0.000564	CcSEcCtD
Lercanidipine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000562	CcSEcCtD
Lercanidipine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000562	CcSEcCtD
Lercanidipine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000556	CcSEcCtD
Lercanidipine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.000555	CcSEcCtD
Lercanidipine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00055	CcSEcCtD
Lercanidipine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00055	CcSEcCtD
Lercanidipine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000192	0.000549	CcSEcCtD
Lercanidipine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.000547	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000543	CcSEcCtD
Lercanidipine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00019	0.000543	CcSEcCtD
Lercanidipine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00019	0.000542	CcSEcCtD
Lercanidipine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00054	CcSEcCtD
Lercanidipine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000189	0.000538	CcSEcCtD
Lercanidipine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000188	0.000536	CcSEcCtD
Lercanidipine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000536	CcSEcCtD
Lercanidipine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000187	0.000534	CcSEcCtD
Lercanidipine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.00053	CcSEcCtD
Lercanidipine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000529	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000526	CcSEcCtD
Lercanidipine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000184	0.000526	CcSEcCtD
Lercanidipine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000184	0.000525	CcSEcCtD
Lercanidipine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000523	CcSEcCtD
Lercanidipine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000521	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000183	0.000521	CcSEcCtD
Lercanidipine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000183	0.000521	CcSEcCtD
Lercanidipine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000182	0.00052	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00052	CcSEcCtD
Lercanidipine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000517	CcSEcCtD
Lercanidipine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000517	CcSEcCtD
Lercanidipine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000181	0.000516	CcSEcCtD
Lercanidipine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000515	CcSEcCtD
Lercanidipine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.000511	CcSEcCtD
Lercanidipine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000179	0.00051	CcSEcCtD
Lercanidipine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000508	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000502	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000502	CcSEcCtD
Lercanidipine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000174	0.000497	CcSEcCtD
Lercanidipine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.000495	CcSEcCtD
Lercanidipine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000495	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000173	0.000493	CcSEcCtD
Lercanidipine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000173	0.000493	CcSEcCtD
Lercanidipine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000492	CcSEcCtD
Lercanidipine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000487	CcSEcCtD
Lercanidipine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000487	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000487	CcSEcCtD
Lercanidipine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000485	CcSEcCtD
Lercanidipine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000484	CcSEcCtD
Lercanidipine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000482	CcSEcCtD
Lercanidipine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000481	CcSEcCtD
Lercanidipine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000168	0.000479	CcSEcCtD
Lercanidipine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000478	CcSEcCtD
Lercanidipine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000478	CcSEcCtD
Lercanidipine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000477	CcSEcCtD
Lercanidipine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000167	0.000477	CcSEcCtD
Lercanidipine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000167	0.000477	CcSEcCtD
Lercanidipine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000476	CcSEcCtD
Lercanidipine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000166	0.000474	CcSEcCtD
Lercanidipine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000473	CcSEcCtD
Lercanidipine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00047	CcSEcCtD
Lercanidipine—Rash—Vincristine—peripheral nervous system neoplasm	0.000165	0.00047	CcSEcCtD
Lercanidipine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000165	0.000469	CcSEcCtD
Lercanidipine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000469	CcSEcCtD
Lercanidipine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000468	CcSEcCtD
Lercanidipine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000467	CcSEcCtD
Lercanidipine—Headache—Vincristine—peripheral nervous system neoplasm	0.000164	0.000467	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000464	CcSEcCtD
Lercanidipine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000459	CcSEcCtD
Lercanidipine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000458	CcSEcCtD
Lercanidipine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000451	CcSEcCtD
Lercanidipine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00045	CcSEcCtD
Lercanidipine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000445	CcSEcCtD
Lercanidipine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000156	0.000445	CcSEcCtD
Lercanidipine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000444	CcSEcCtD
Lercanidipine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000155	0.000442	CcSEcCtD
Lercanidipine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000442	CcSEcCtD
Lercanidipine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000442	CcSEcCtD
Lercanidipine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000442	CcSEcCtD
Lercanidipine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000441	CcSEcCtD
Lercanidipine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000435	CcSEcCtD
Lercanidipine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000434	CcSEcCtD
Lercanidipine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000152	0.000433	CcSEcCtD
Lercanidipine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000433	CcSEcCtD
Lercanidipine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000432	CcSEcCtD
Lercanidipine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000432	CcSEcCtD
Lercanidipine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00043	CcSEcCtD
Lercanidipine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000429	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00015	0.000427	CcSEcCtD
Lercanidipine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000421	CcSEcCtD
Lercanidipine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000419	CcSEcCtD
Lercanidipine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000417	CcSEcCtD
Lercanidipine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000417	CcSEcCtD
Lercanidipine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000415	CcSEcCtD
Lercanidipine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000415	CcSEcCtD
Lercanidipine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000414	CcSEcCtD
Lercanidipine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000414	CcSEcCtD
Lercanidipine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000145	0.000413	CcSEcCtD
Lercanidipine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000412	CcSEcCtD
Lercanidipine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000411	CcSEcCtD
Lercanidipine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000409	CcSEcCtD
Lercanidipine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000409	CcSEcCtD
Lercanidipine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000407	CcSEcCtD
Lercanidipine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000406	CcSEcCtD
Lercanidipine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000403	CcSEcCtD
Lercanidipine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.0004	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00014	0.000399	CcSEcCtD
Lercanidipine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000398	CcSEcCtD
Lercanidipine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000398	CcSEcCtD
Lercanidipine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000397	CcSEcCtD
Lercanidipine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000391	CcSEcCtD
Lercanidipine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000391	CcSEcCtD
Lercanidipine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000389	CcSEcCtD
Lercanidipine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000386	CcSEcCtD
Lercanidipine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000385	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000135	0.000384	CcSEcCtD
Lercanidipine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000384	CcSEcCtD
Lercanidipine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000384	CcSEcCtD
Lercanidipine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000383	CcSEcCtD
Lercanidipine—Rash—Etoposide—peripheral nervous system neoplasm	0.000133	0.00038	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000133	0.00038	CcSEcCtD
Lercanidipine—Headache—Etoposide—peripheral nervous system neoplasm	0.000133	0.000378	CcSEcCtD
Lercanidipine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000376	CcSEcCtD
Lercanidipine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000376	CcSEcCtD
Lercanidipine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000374	CcSEcCtD
Lercanidipine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000372	CcSEcCtD
Lercanidipine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000372	CcSEcCtD
Lercanidipine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000372	CcSEcCtD
Lercanidipine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000369	CcSEcCtD
Lercanidipine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000366	CcSEcCtD
Lercanidipine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000364	CcSEcCtD
Lercanidipine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000362	CcSEcCtD
Lercanidipine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000361	CcSEcCtD
Lercanidipine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000126	0.000358	CcSEcCtD
Lercanidipine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000356	CcSEcCtD
Lercanidipine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000354	CcSEcCtD
Lercanidipine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000353	CcSEcCtD
Lercanidipine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000353	CcSEcCtD
Lercanidipine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000353	CcSEcCtD
Lercanidipine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000352	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00035	CcSEcCtD
Lercanidipine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000349	CcSEcCtD
Lercanidipine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000346	CcSEcCtD
Lercanidipine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000345	CcSEcCtD
Lercanidipine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000345	CcSEcCtD
Lercanidipine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000344	CcSEcCtD
Lercanidipine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000341	CcSEcCtD
Lercanidipine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000339	CcSEcCtD
Lercanidipine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000337	CcSEcCtD
Lercanidipine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000335	CcSEcCtD
Lercanidipine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000333	CcSEcCtD
Lercanidipine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000332	CcSEcCtD
Lercanidipine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000331	CcSEcCtD
Lercanidipine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00033	CcSEcCtD
Lercanidipine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000329	CcSEcCtD
Lercanidipine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000327	CcSEcCtD
Lercanidipine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000326	CcSEcCtD
Lercanidipine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000326	CcSEcCtD
Lercanidipine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000326	CcSEcCtD
Lercanidipine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000325	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000324	CcSEcCtD
Lercanidipine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000323	CcSEcCtD
Lercanidipine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000322	CcSEcCtD
Lercanidipine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000319	CcSEcCtD
Lercanidipine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000316	CcSEcCtD
Lercanidipine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000316	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000308	CcSEcCtD
Lercanidipine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000308	CcSEcCtD
Lercanidipine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000307	CcSEcCtD
Lercanidipine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000306	CcSEcCtD
Lercanidipine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000306	CcSEcCtD
Lercanidipine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000305	CcSEcCtD
Lercanidipine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000304	CcSEcCtD
Lercanidipine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000304	CcSEcCtD
Lercanidipine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000303	CcSEcCtD
Lercanidipine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000302	CcSEcCtD
Lercanidipine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000301	CcSEcCtD
Lercanidipine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000298	CcSEcCtD
Lercanidipine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000298	CcSEcCtD
Lercanidipine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000294	CcSEcCtD
Lercanidipine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000292	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000292	CcSEcCtD
Lercanidipine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000292	CcSEcCtD
Lercanidipine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000289	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000285	CcSEcCtD
Lercanidipine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000283	CcSEcCtD
Lercanidipine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.86e-05	0.000281	CcSEcCtD
Lercanidipine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.79e-05	0.000279	CcSEcCtD
Lercanidipine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.78e-05	0.000279	CcSEcCtD
Lercanidipine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000278	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000277	CcSEcCtD
Lercanidipine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000276	CcSEcCtD
Lercanidipine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000272	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.00027	CcSEcCtD
Lercanidipine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.46e-05	0.00027	CcSEcCtD
Lercanidipine—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000269	CcSEcCtD
Lercanidipine—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000268	CcSEcCtD
Lercanidipine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.38e-05	0.000267	CcSEcCtD
Lercanidipine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.38e-05	0.000267	CcSEcCtD
Lercanidipine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.05e-05	0.000258	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000256	CcSEcCtD
Lercanidipine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000249	CcSEcCtD
Lercanidipine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000249	CcSEcCtD
Lercanidipine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.68e-05	0.000247	CcSEcCtD
Lercanidipine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.68e-05	0.000247	CcSEcCtD
Lercanidipine—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000243	CcSEcCtD
Lercanidipine—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000239	CcSEcCtD
Lercanidipine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.12e-05	0.000231	CcSEcCtD
Lercanidipine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000231	CcSEcCtD
Lercanidipine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.000225	CcSEcCtD
Lercanidipine—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000224	CcSEcCtD
Lercanidipine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000221	CcSEcCtD
Lercanidipine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000215	CcSEcCtD
Lercanidipine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000214	CcSEcCtD
Lercanidipine—Rash—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000213	CcSEcCtD
Lercanidipine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000213	CcSEcCtD
Lercanidipine—Headache—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000212	CcSEcCtD
Lercanidipine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.26e-05	0.000207	CcSEcCtD
Lercanidipine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000201	CcSEcCtD
Lercanidipine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000199	CcSEcCtD
Lercanidipine—Rash—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000197	CcSEcCtD
Lercanidipine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000197	CcSEcCtD
Lercanidipine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.88e-05	0.000196	CcSEcCtD
Lercanidipine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000186	CcSEcCtD
